Akero Therapeutics (AKRO) PT Raised to $58 at Canaccord Genuity

March 20, 2023 11:55 AM EDT Send to a Friend
Canaccord Genuity analyst Edward Nash ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login